# Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (Text with EEA relevance), Division 2

Extent: E+W+S+N.I.

If possible, the immune mechanism (cell-mediated/humoral, local/general classes of immunoglobulin) which is initiated after the administration of the immunological veterinary medicinal product to target animals by the recommended route of administration shall be specified and documented.

---
Source: https://www.legislation.gov.uk/eur/2019/6/annex/II/title/II/chapter/II/division/B/division/2 (the official version)
Page: https://openlegislation.uk/eu-regulation-2019-6/annex-II/title-II/chapter-II/division-B/division-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.